Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Jul;34(7):1765–1768. doi: 10.1128/jcm.34.7.1765-1768.1996

Emergence of teicoplanin-resistant coagulase-negative staphylococci.

E Cercenado 1, M E García-Leoni 1, M D Díaz 1, C Sánchez-Carrillo 1, P Catalán 1, J C De Quirós 1, E Bouza 1
PMCID: PMC229110  PMID: 8784585

Abstract

Over a period of 5 years we have recovered 32 clinical isolates of coagulase-negative staphylococci (CoNS) exhibiting either decreased levels of susceptibility or true resistance to teicoplanin (MICs, 16 to 128 micrograms/ml); these isolates make up 0.55% of the total CoNS isolated by us. Twenty-nine of the strains were also methicillin resistant, and all were susceptible to vancomycin. Fourteen of the strains were Staphylococcus epidermidis, fourteen were Staphylococcus haemolyticus, and four were Staphylococcus hominis. In one case, a strain of S. haemolyticus was isolated with a vancomycin-resistant, teicoplanin-resistant Enterococcus faecalis strain. All strains were nosocomially acquired and were isolated from 17 different wards. Teicoplanin resistance occurred as a sporadic phenomenon, and none of the isolates were epidemiologically related. The isolates were from 30 patients, 13 of whom presented with true infections (43%). Five (38%) of the 13 patients with true infections had been previously treated with vancomycin. None of the infected patients were previously treated with teicoplanin. The in vivo development of resistance to teicoplanin among CoNS strains limits the therapy of infections by these microorganisms. There is a need for surveillance of nosocomial isolates of CoNS to determine resistance to glycopeptides.

Full Text

The Full Text of this article is available as a PDF (222.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldridge K. E. In vitro antistaphylococcal activities of two investigative fluoroquinolones, CI-960 and WIN 57273, compared with those of ciprofloxacin, mupirocin (pseudomonic acid), and peptide-class antimicrobial agents. Antimicrob Agents Chemother. 1992 Apr;36(4):851–853. doi: 10.1128/aac.36.4.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amsterdam D., Gorzynski E. A., Beam T. R., Rotstein C. Susceptibility of bacteraemic isolates of gram-positive cocci to daptomycin and other antimicrobial agents. J Antimicrob Chemother. 1994 May;33(5):1060–1064. doi: 10.1093/jac/33.5.1060. [DOI] [PubMed] [Google Scholar]
  3. Archer G. L., Climo M. W. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother. 1994 Oct;38(10):2231–2237. doi: 10.1128/aac.38.10.2231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aubert G., Passot S., Lucht F., Dorche G. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection. J Antimicrob Chemother. 1990 Mar;25(3):491–493. doi: 10.1093/jac/25.3.491. [DOI] [PubMed] [Google Scholar]
  5. Bannerman T. L., Wadiak D. L., Kloos W. E. Susceptibility of Staphylococcus species and subspecies to teicoplanin. Antimicrob Agents Chemother. 1991 Sep;35(9):1919–1922. doi: 10.1128/aac.35.9.1919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bourgeois F., Bingen E., Lambert-Zechovsky N. Activité comparée in vitro des glycopeptides sur les staphylocoques coagulase négative isolés en pédiatrie. Pathol Biol (Paris) 1992 Jan;40(1):36–39. [PubMed] [Google Scholar]
  7. Desroys Du Roure F., Herrmann J. L., Lagrange P. H., Bouvet A. Activité de la teicoplanine vis-à-vis des staphylocoques à coagulase négative (SCN) au sein des services hospitaliers de l'Hôtel-Dieu de Paris. Pathol Biol (Paris) 1993 Apr;41(4):302–306. [PubMed] [Google Scholar]
  8. Forbes B. A., Schaberg D. R. Transfer of resistance plasmids from Staphylococcus epidermidis to Staphylococcus aureus: evidence for conjugative exchange of resistance. J Bacteriol. 1983 Feb;153(2):627–634. doi: 10.1128/jb.153.2.627-634.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goldstein F. W., Coutrot A., Sieffer A., Acar J. F. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother. 1990 May;34(5):899–900. doi: 10.1128/aac.34.5.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hunter P. R., George R. C., Griffiths J. W. Mathematical modeling of antimicrobial susceptibility data of Staphylococcus haemolyticus for 11 antimicrobial agents, including three experimental glycopeptides and an experimental lipoglycopeptide. Antimicrob Agents Chemother. 1990 Sep;34(9):1769–1772. doi: 10.1128/aac.34.9.1769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jaffe H. W., Sweeney H. M., Nathan C., Weinstein R. A., Kabins S. A., Cohen S. Identity and interspecific transfer of gentamicin-resistance plasmids in Staphylococcus aureus and Staphylococcus epidermidis. J Infect Dis. 1980 Jun;141(6):738–747. doi: 10.1093/infdis/141.6.738. [DOI] [PubMed] [Google Scholar]
  12. Jean-Pierre H., Rivière M., Darbas H., Boyer G. Activité in vitro des glycopeptides sur 114 staphylocoques à coagulase négative: problèmes du test en diffusion pour la teicoplanine, paramètres "d'alerte" incitant au contrôle de la CMI. Pathol Biol (Paris) 1993 Jun;41(6):531–536. [PubMed] [Google Scholar]
  13. Karchmer A. W., Archer G. L., Dismukes W. E. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med. 1983 Apr;98(4):447–455. doi: 10.7326/0003-4819-98-4-447. [DOI] [PubMed] [Google Scholar]
  14. Mainardi J. L., Shlaes D. M., Goering R. V., Shlaes J. H., Acar J. F., Goldstein F. W. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J Infect Dis. 1995 Jun;171(6):1646–1650. doi: 10.1093/infdis/171.6.1646. [DOI] [PubMed] [Google Scholar]
  15. Maki D. G., Weise C. E., Sarafin H. W. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977 Jun 9;296(23):1305–1309. doi: 10.1056/NEJM197706092962301. [DOI] [PubMed] [Google Scholar]
  16. Maugein J., Pellegrin J. L., Brossard G., Fourche J., Leng B., Reiffers J. In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients. Antimicrob Agents Chemother. 1990 May;34(5):901–903. doi: 10.1128/aac.34.5.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. O'Hare M. D., Reynolds P. E. Novel membrane proteins present in teicoplanin-resistant, vancomycin-sensitive, coagulase-negative Staphylococcus spp. J Antimicrob Chemother. 1992 Dec;30(6):753–768. doi: 10.1093/jac/30.6.753. [DOI] [PubMed] [Google Scholar]
  18. Pfaller M. A., Herwaldt L. A. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev. 1988 Jul;1(3):281–299. doi: 10.1128/cmr.1.3.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schwalbe R. S., Stapleton J. T., Gilligan P. H. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987 Apr 9;316(15):927–931. doi: 10.1056/NEJM198704093161507. [DOI] [PubMed] [Google Scholar]
  20. Tennent J. M., May J. W., Skurray R. A. Multiple antibiotic resistance in Staphylococcus aureus and Staphylococcus epidermidis: plasmids in strains associated with nosocomial infection. Pathology. 1984 Jul;16(3):250–255. doi: 10.3109/00313028409068532. [DOI] [PubMed] [Google Scholar]
  21. Veach L. A., Pfaller M. A., Barrett M., Koontz F. P., Wenzel R. P. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol. 1990 Sep;28(9):2064–2068. doi: 10.1128/jcm.28.9.2064-2068.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Vedel G., Leruez M., Lémann F., Hraoui E., Ratovohery D. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs. Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):820–822. doi: 10.1007/BF01967381. [DOI] [PubMed] [Google Scholar]
  23. Wilson A. P., O'Hare M. D., Felmingham D., Grüneberg R. N. Teicoplanin-resistant coagulase-negative staphylococcus. Lancet. 1986 Oct 25;2(8513):973–973. doi: 10.1016/s0140-6736(86)90622-7. [DOI] [PubMed] [Google Scholar]
  24. Woodford N., Johnson A. P., Morrison D., Speller D. C. Current perspectives on glycopeptide resistance. Clin Microbiol Rev. 1995 Oct;8(4):585–615. doi: 10.1128/cmr.8.4.585. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES